| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 01/31/2002 | DE10035011A1 Pure N,N'-carbonyl-diazole preparation in high yield, by reacting azolide salt with phosgene in aromatic or ether solvent |
| 01/31/2002 | DE10034802A1 Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren Stable salts of O-acetylsalicylic acid with basic amino acids |
| 01/31/2002 | CA2417426A1 Efficient ligand-mediated ullmann coupling of anilines and azoles |
| 01/31/2002 | CA2417127A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | CA2416870A1 Potassium channel inhibitors |
| 01/31/2002 | CA2416865A1 Potassium channel inhibitors |
| 01/31/2002 | CA2415362A1 Method for treating fibrotic diseases or other indications |
| 01/31/2002 | CA2415054A1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 01/31/2002 | CA2410766A1 Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | CA2410562A1 Colchinol derivatives as angiogenesis inhibitors |
| 01/30/2002 | EP1176141A1 HETEROCYCLIC COMPOUNDS HAVING EFFECT OF ACTIVATING NICOTINIC ACETYLCHOLINE $g(a)4$g(b)2 RECEPTOR |
| 01/30/2002 | EP1175406A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands |
| 01/30/2002 | EP1175383A1 Glucocorticoid receptor modulators |
| 01/30/2002 | EP1175214A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 01/30/2002 | EP1175213A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/30/2002 | CN1333782A New derivatives of erythromycin, process for making them and use as medicaments |
| 01/30/2002 | CN1333769A Thiourea inhibitors of herps viruses |
| 01/29/2002 | US6342765 Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
| 01/29/2002 | US6342516 Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
| 01/29/2002 | US6342508 N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/29/2002 | CA2094390C N-substituted imidazol-2-one compounds for treatment of circulatory disorders |
| 01/24/2002 | WO2002006349A1 Gel compositions containing metronidazole |
| 01/24/2002 | WO2002006215A1 3-arylsulfonyl-2-hydroxy-2-methylpropanoic acid derivates |
| 01/24/2002 | WO2002005782A2 Stable salts of o-acetylsalicyclic with basic amino acids |
| 01/24/2002 | WO2001058869A3 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 01/24/2002 | WO2001027107A3 Heterocyclic sodium/proton exchange inhibitors and method |
| 01/24/2002 | US20020010338 Phenyl-keto-imidazolidine thioamide derivatives |
| 01/24/2002 | US20020010173 Reacting an amide derivative with a piperidine containing guanidine group to produce the product |
| 01/24/2002 | US20020009650 High electroconductivity |
| 01/24/2002 | DE10130740A1 Malonic acid monoester and beta-keto-ester preparation from epoxide in high yield, for use as intermediates, by hydroesterification over cobalt compound catalyst followed by catalytic oxygenation |
| 01/23/2002 | EP1174135A2 Pharmaceutical composition for use in treatment of diabetes |
| 01/23/2002 | EP1173414A1 N-protected amines and their use as prodrugs |
| 01/23/2002 | EP1173169A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 01/23/2002 | CN1332723A Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 01/23/2002 | CN1332722A 2-substituted Retoamides |
| 01/23/2002 | CN1332167A Eprosartan dihydrate and its prep. |
| 01/22/2002 | US6340371 Cationic ortho-phenylenediamines, their use for the oxidation dyeing of keratin fibers, dye compositions and dyeing processes |
| 01/22/2002 | CA2064872C Aryloxymethylcarbonochloridate ester intermediates, their production and use in synthesizing prodrugs and their use therefor |
| 01/22/2002 | CA2049882C Process for iodinating or brominating the alpha-methylenic carbon of a secondary amide |
| 01/22/2002 | CA2038848C Hydantoin derivatives |
| 01/22/2002 | CA2027876C Use of substituted imidazoles |
| 01/17/2002 | WO2002003912A2 Novel c-4 substituted retinoids |
| 01/17/2002 | US20020007074 Imidazole derivatives having affinity for alpha2 receptors |
| 01/17/2002 | US20020007062 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders |
| 01/17/2002 | US20020007045 For inhibiting the aggregation of blood platelets; 3-(4-Aminomethyl-phenyl)-1-(2-(3,4-dichloro-phenyl)-2-hydroxy-ethyl)-1 -isopropyl-urea for example |
| 01/17/2002 | US20020006951 Solid-state form of celecoxib having enhanced bioavailability |
| 01/17/2002 | US20020006936 Anticancer agents; restenosis |
| 01/17/2002 | US20020006929 Antiarrhythmia agent, antiproliferative agent |
| 01/17/2002 | US20020006922 Metalloprotease inhibitors |
| 01/17/2002 | DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments |
| 01/17/2002 | DE10010984A1 Preparation of 2-phenyl-4,5-dihydro-oxazole-5-carboxylic acid derivatives, used as intermediates, by catalytic cyclization of N-benzoyl-aminoalkene compound |
| 01/16/2002 | EP1019095B1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates |
| 01/16/2002 | EP0638075B1 Thiazole or imidazole derivatives as maillard reaction inhibitors |
| 01/16/2002 | CN1331681A Synthesis of histamine dihydrochloride |
| 01/16/2002 | CN1331680A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/16/2002 | CN1077886C Amidino derivatives useful as nitric oxide synthase inhibitors |
| 01/16/2002 | CN1077878C Prepn. of bicyclohexane derivative |
| 01/15/2002 | US6339099 Guanidine mimics as factor Xa inhibitors |
| 01/15/2002 | US6339082 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
| 01/15/2002 | US6339081 Composition and use |
| 01/15/2002 | US6338960 Histamine measuring apparatus and a histamine measuring method |
| 01/10/2002 | WO2002002567A1 Thienopyrrolidinones |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002218A1 Catalysis in an ionic fluid, supercritical fluid two phase system |
| 01/10/2002 | US20020004512 Sexual disorders |
| 01/10/2002 | US20020004503 Viricides |
| 01/10/2002 | CA2414705A1 Thienopyrrolidinones |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1170289A2 Retroviral protease inhibiting compounds |
| 01/09/2002 | EP1170288A2 Diphenylureum derivatives and their use as alpha2/5-HT2c antagonists |
| 01/09/2002 | EP1169312A2 Glucokinase activators |
| 01/09/2002 | EP1169301A1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 01/09/2002 | EP1169298A2 Pharmaceutical compounds |
| 01/09/2002 | EP1169294A2 Pharmaceutical compounds |
| 01/09/2002 | EP1169038A1 Cyclic protein tyrosine kinase inhibitors |
| 01/09/2002 | EP1169031A1 Antimicrobial agents |
| 01/09/2002 | CN1330640A Cyclic hydrazine derivatives as TNF-alpha inhibitors |
| 01/09/2002 | CN1330064A Method for producing malonate derivative or beta-ket-acid ester by epoxide derivative |
| 01/09/2002 | CN1077570C Sulfamate compounds containing N-substituted carbanoyl and process for preparing the same |
| 01/08/2002 | US6337340 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
| 01/08/2002 | US6337178 Quantitative analysis; measuring electrode potential |
| 01/03/2002 | WO2002000659A2 Methods of synthesis for 9-substituted hypoxanthine derivatives |
| 01/03/2002 | WO2002000647A1 Heteroaryl-phenyl substituted factor xa inhibitors |
| 01/03/2002 | WO2001070693A3 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 01/03/2002 | WO2000061549A3 Pharmaceutical compounds |
| 01/03/2002 | US20020002307 Process for the selective N-formylation of N-hydroxylamines |
| 01/03/2002 | US20020002195 Pesticidal 1-polyarylpyrazoles |
| 01/03/2002 | US20020002186 Pharmaceutical composition |
| 01/03/2002 | DE10030893A1 New N-(2'-hydroxy-5'-aminobenzyl)-2-oxo- and -2-imino-thiazol(id)ine and -imidazol(id)ine compounds are used as developer component in oxidation colorant for keratin fibers, especially hair |
| 01/03/2002 | DE10030685A1 Production of aliphatic sulfonic acid chlorides, useful for the production of agrochemicals, comprises reacting with phosgene in the presence of dimehtylformamide and a base or a sulfonic acid salt of a base |
| 01/03/2002 | CA2409762A1 Heteroaryl-phenyl substituted factor xa inhibitors |
| 01/02/2002 | EP1167356A2 Wet adhesion monomer and derived copolymers for latex paints |
| 01/02/2002 | EP1166768A1 Use of ergothioneine and its derivatives as a glycation inhibitor |
| 01/02/2002 | EP1165547A1 Substituted benzoylpyrazoles as herbicides |
| 01/02/2002 | EP1165530A2 Dihetero-substituted metalloprotease inhibitors |
| 01/02/2002 | EP1165512A2 Method for arylating aza-heterocycles with activated aromatic compounds in the presence of cesium carbonate |
| 01/02/2002 | EP1165511A2 Method of producing heterocyclic carbamates from aza-heterocyclic compounds and carbon dioxide |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | EP1165504A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
| 01/02/2002 | EP1165492A1 Hydroxyphenyl derivatives with hiv integrase inhibitory properties |